-
Media ReleaseNovartis contributes to rebuilding PH post-pandemic economy, strengthening country's health care system
-
Media ReleaseNovartis medicine, ribociclib, prolongs progression-free survival for pre- and perimenopausal patients with aggressive HR+/HER2− metastatic breast cancer compared to chemotherapy
-
Media ReleaseNovartis' Ribociclib Phase III NATALEE trial shows significant benefit for patients with early breast cancer in interim analysis
-
Media ReleasePhilippine FDA approves Novartis medicine brolucizumab for the treatment of visual impairment due to diabetic macular edema
-
Media ReleaseNovartis Healthcare Philippines recognized as a Top Employer for third consecutive year